Published in Arch Dis Child on April 01, 1998
Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature (2011) 2.82
Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med (2013) 1.34
Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells. Arthritis Res Ther (2012) 1.00
Idiopathic CD4 lymphocytopenia presenting as refractory cryptococcal meningitis. Ann Indian Acad Neurol (2010) 0.95
A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. Blood (2011) 0.95
Idiopathic CD4+ T-lymphocytopenia in a boy with Down syndrome. Report of a patient and a review of the literature. Eur J Pediatr (2003) 0.85
Idiopathic CD4+ lymphocytopenia in Hispanic male: case report and literature review. Int Med Case Rep J (2014) 0.81
NIH conference. New insights into common variable immunodeficiency. Ann Intern Med (1993) 2.52
Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr (1993) 1.43
Unusual phenotypes of human inducer T cells as measured by OKT4 and related monoclonal antibodies. J Immunol (1981) 1.18
CD4+ T lymphocytopenia in children: lack of evidence for a new acquired immunodeficiency syndrome agent. Pediatr Infect Dis J (1995) 1.02
B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia. Leuk Lymphoma (1996) 0.89
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
The impact of managed care on patients' trust in medical care and their physicians. JAMA (1996) 3.61
Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 2.96
HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci U S A (1988) 2.72
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature (1965) 2.54
Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet (1999) 2.42
Privatization of psychiatric services. Am J Psychiatry (1988) 2.38
Antigens of the thymus. Prog Allergy (1972) 2.36
The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J Immunol (1974) 2.19
Initiation sites for translation of sindbis virus 42S and 26S messenger RNAs. Cell (1975) 1.94
How to improve estimates of imprecision. Clin Chem (1984) 1.92
Management of mental health and substance abuse services: state of the art and early results. Milbank Q (1995) 1.90
A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 1.87
Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet (1992) 1.85
Antigenic changes in lymph-node cells after administration of antiserum to thymus cells. Science (1969) 1.80
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Serologic demonstration of a thymus-dependent population of lymph-node cells. J Immunol (1970) 1.79
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A (1987) 1.77
Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum (1978) 1.74
Successful methotrexate treatment of a viable pregnancy within a thin uterine scar. Br J Obstet Gynaecol (1997) 1.73
Lung involvement and enzyme replacement therapy in Gaucher's disease. QJM (2001) 1.70
On the limits of expanding health care reform: chronic care in prepaid settings. Milbank Q (1986) 1.67
Hemoglobin interaction: modification of solid phase composition in the sickling phenomenon. Science (1970) 1.64
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum (1982) 1.62
Cigarette smoking habits among schoolchildren. Chest (1996) 1.61
Anti-theta antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC. Nature (1970) 1.61
T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol (1983) 1.58
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet (1997) 1.56
Absent gallbladder on fetal ultrasound: prenatal findings and postnatal outcome. Ultrasound Obstet Gynecol (2011) 1.55
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Time domain dielectric spectroscopy study of human cells. II. Normal and malignant white blood cells. Biochim Biophys Acta (1999) 1.54
HLA polymorphism in Israel. 9. An overall comparative analysis. Tissue Antigens (1978) 1.54
Genetic variation of three tetrameric tandem repeats in four distinct Israeli ethnic groups. J Forensic Sci (1999) 1.53
A broader vision for managed care, Part 1: Measuring the benefit to communities. Health Aff (Millwood) (1998) 1.51
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum (1982) 1.51
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. Am J Obstet Gynecol (2000) 1.45
Defective virus particles from Sindbis virus. Virology (1972) 1.44
Effector T lymphocyte line cells migrate to the thymus and persist there. Nature (1982) 1.44
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature (1984) 1.42
Nesidiodysplasia--a histologic entity? Hum Pathol (1988) 1.42
Some aspects of the humoral and neutrophil functions in post-comatose nawareness patients. Brain Inj (1993) 1.42
Accessory nipples: any relationship to urinary tract malformation? Pediatr Dermatol (1992) 1.41
Absence of natural killer cells in a child with pure red blood cell aplasia. Am J Hematol (1990) 1.39
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A (1986) 1.38
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med (2000) 1.37
Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity. Proc Natl Acad Sci U S A (1994) 1.37
The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity (1997) 1.35
Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation. Lancet (1993) 1.32
Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol (1998) 1.32
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet (1984) 1.31
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens (2004) 1.31
A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science (1988) 1.28
Homology of the NH2-terminal amino acid sequences of the heavy and light chains of human monoclonal lupus autoantibodies containing the dominant 16/6 idiotype. J Clin Invest (1985) 1.26
Transitional cell carcinoma of the bladder in the pediatric patient. J Urol (1996) 1.26
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med (1982) 1.26
Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol (2001) 1.25
T lymphocyte lines induce autoimmune encephalomyelitis, delayed hypersensitivity and bystander encephalitis or arthritis. Eur J Immunol (1984) 1.25
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
Thymic deficiency in Down's syndrome. Pediatrics (1979) 1.23
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol (1990) 1.22
Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med (1995) 1.20
Spontaneous occurrence of autoantibodies cytotoxic to thymus cells in the sera of mice of the 129 strain. Nature (1965) 1.20
Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol (1987) 1.19
Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J (2001) 1.19
HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens (1982) 1.19
Genitourinary anomalies associated with Klippel-Feil syndrome. J Bone Joint Surg Am (1975) 1.18
The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet (1996) 1.16
Shared idiotypes are expressed on mouse and human anti-DNA autoantibodies. Immunology (1985) 1.15
HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome. Am J Med (1987) 1.15
Effect of neuraminidase on serological properties of murine lymphoid cells. Transplant Proc (1971) 1.13
Does urinary tract ultrasonography at hospitalization for acute pyelonephritis predict vesicoureteral reflux? J Urol (2001) 1.12
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum (1999) 1.12
The P.A.D.U.A. (progressive augmentation by dilating the urethra anterior) procedure for the treatment of severe urethral hypoplasia. J Urol (1988) 1.11
Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A (1987) 1.11
Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity. J Immunol (1975) 1.11
Maternal-paternal histocompatibility: lack of association with habitual abortions. Fertil Steril (1984) 1.10
Characterization of cytotoxic isoantisera produced in R3 mice. I. Demonstration of antibodies against the theta-C3H isoantigen. Transplantation (1969) 1.09
Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol (1988) 1.09
Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients. J Immunol (1985) 1.09
The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer (1976) 1.09
HLA-DRw4 in pemphigus vulgaris patients in Israel. Tissue Antigens (1980) 1.08
Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens (1981) 1.08
Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population. Health Econ (1994) 1.08
In vitro production of an anti-DNA idiotype by lymphocytes of normal subjects and patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1986) 1.08
Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer (1980) 1.06
Cystic fibrosis in Jews: frequency and mutation distribution. Genet Test (1997) 1.06
Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med (1983) 1.06
Immune competence of newborn lymphocytes. Pediatrics (1980) 1.05
Suppressors of cancer cell proliferation from fig (Ficus carica) resin: isolation and structure elucidation. J Nat Prod (2001) 1.05